Our Leadership - Catalent Biologics

Home

About Us

Our Leadership

Catalent has attracted a world-class array of strategic and operational talent to lead us into cutting-edge innovation and reliable supply for our customers. Meet our Biologics and Cell & Gene Therapy Senior Leadership Teams below.

Biologics Leadership Cell & Gene Therapy Leadership
Biologics Advisory Board Redwood Scientific Advisory Board

Biologics Leadership

KAREN FLYNN

President, Biologics &
Chief Commercial Officer

MARIO GARGIULO

Region President,
Biologics, Europe

MIKE RILEY

Region President,
Biologics,
North America

VIC VINCI, PH.D.

Vice President, Product Development

Meet the Catalent Biologics Commercial Team

Cell & Gene Therapy Leadership

Biologics Advisory Board

CAROLYN BERTOZZI,
PH.D.

BARRY BUCKLAND,
PH.D.

MICHAEL BUCKLEY,
PH.D.

DANIEL R. MARSHAK,
PH.D.

EDWARD R. ROBINSON

DAVID SCHAFFER,
PH.D.

MATTHEW STOBER

Redwood Scientific Advisory Board

CAROLYN BERTOZZI,
PH.D.

BENJAMIN G. DAVIS,
PH.D.

THOMAS MUIR,
PH.D.

ANDREW SIMMONS,
PH.D.

TED YEDNOCK,
PH.D.

Meet the Catalent Executive Leadership Team and Board of Directors